Filing Details

Accession Number:
0002049575-24-000001
Form Type:
13G Filing
Publication Date:
2024-12-19 19:00:00
Filed By:
V-CO Investors LLC
Company:
Vivos Therapeutics Inc.
Filing Date:
2024-12-20
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
V-CO Investors LLC 0 514,498 9.9%
SP Manager LLC 0 514,498 9.9%
Michael Skaff 0 514,498 9.9%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  The percentage is calculated based upon the sum of (i) 4,835,300 shares of Common Stock issued and outstanding as of November 14, 2024, as reported in the Issuer's quarterly report on Form 10-Q filed with the SEC on November 14, 2024, plus (ii) 345,000 shares of Common Stock issued upon the partial exercise of a certain pre-funded warrant held by V-CO Investors LLC.


SCHEDULE 13G



Comment for Type of Reporting Person:  The percentage is calculated based upon the sum of (i) 4,835,300 shares of Common Stock issued and outstanding as of November 14, 2024, as reported in the Issuer's quarterly report on Form 10-Q filed with the SEC on November 14, 2024, plus (ii) 345,000 shares of Common Stock issued upon the partial exercise of a certain pre-funded warrant held by V-CO Investors LLC.


SCHEDULE 13G



Comment for Type of Reporting Person:  The percentage is calculated based upon the sum of (i) 4,835,300 shares of Common Stock issued and outstanding as of November 14, 2024, as reported in the Issuer's quarterly report on Form 10-Q filed with the SEC on November 14, 2024, plus (ii) 345,000 shares of Common Stock issued upon the partial exercise of a certain pre-funded warrant held by V-CO Investors LLC.


SCHEDULE 13G


 
V-CO Investors LLC
 
Signature:Michael Skaff
Name/Title:Michael Skaff, Managing Director of SP Manager LLC
Date:12/20/2024
 
SP Manager LLC
 
Signature:Michael Skaff*
Name/Title:Managing Director
Date:12/20/2024
 
Michael Skaff
 
Signature:Michael Skaff*
Name/Title:Individual
Date:12/20/2024

Comments accompanying signature:  * This Reporting Person disclaims beneficial ownership of these reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that any such person is the beneficial owner of these securities for purposes of Section 16 of the U.S. Securities Exchange Act of 1934, as amended, or for any other purpose.